Nanopharmaceuticals II: Application of nanoparticles and nanocarrier systems in pharmaceutics and nanomedicine

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The principle aim of using nanoparticles in pharmaceutical delivery systems is to enable targeted and efficient delivery of the appropriate levels of therapeutic or diagnostic agents to the target sites with reduced, if any, side effects to the patient. Given the benefits that nanotechnology offers, much effort has focused on producing nanoparticles for the delivery of drugs (particularly anti-tumour drugs), photosensitisers, diagnostic agents and vaccines. These nanosystems can be modified to achieve desirable biological properties (e.g., long circulation in blood, targeting delivery, stimuli sensitivity and intracellular target) and perform various therapeutically or diagnostically important functions simultaneously. This paper reviews the application of nanoparticulate systems in vaccination, chemotherapy, photodynamic therapy, diagnostics, and drug/gene delivery. Multifunctional nanocarriers are also described. Additionally, nanopharmaceutical product development and related issues are briefly presented.

Original languageEnglish (US)
Pages (from-to)115-145
Number of pages31
JournalInternational Journal of Nanotechnology
Volume8
Issue number1-2
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Medical nanotechnology
delivery
Nanoparticles
Nanosystems
nanoparticles
Photodynamic therapy
Photosensitizers
Chemotherapy
Vaccines
Nanotechnology
drugs
Product development
Pharmaceutical Preparations
Drug products
Tumors
Blood
Genes
Photosensitizing Agents
vaccines
product development

Keywords

  • Chemotherapy
  • Diagnostics
  • Multifunctional
  • Nanomedicine
  • Nanoparticles
  • Photodynamic therapy
  • Theragnostics
  • Therapeutics
  • Vaccination

ASJC Scopus subject areas

  • Electrical and Electronic Engineering
  • Materials Chemistry
  • Condensed Matter Physics
  • Bioengineering

Cite this

@article{1bcf5f9c2e4246588d6a1b7bd4961ba5,
title = "Nanopharmaceuticals II: Application of nanoparticles and nanocarrier systems in pharmaceutics and nanomedicine",
abstract = "The principle aim of using nanoparticles in pharmaceutical delivery systems is to enable targeted and efficient delivery of the appropriate levels of therapeutic or diagnostic agents to the target sites with reduced, if any, side effects to the patient. Given the benefits that nanotechnology offers, much effort has focused on producing nanoparticles for the delivery of drugs (particularly anti-tumour drugs), photosensitisers, diagnostic agents and vaccines. These nanosystems can be modified to achieve desirable biological properties (e.g., long circulation in blood, targeting delivery, stimuli sensitivity and intracellular target) and perform various therapeutically or diagnostically important functions simultaneously. This paper reviews the application of nanoparticulate systems in vaccination, chemotherapy, photodynamic therapy, diagnostics, and drug/gene delivery. Multifunctional nanocarriers are also described. Additionally, nanopharmaceutical product development and related issues are briefly presented.",
keywords = "Chemotherapy, Diagnostics, Multifunctional, Nanomedicine, Nanoparticles, Photodynamic therapy, Theragnostics, Therapeutics, Vaccination",
author = "Xiao Wu and Mansour, {Heidi -}",
year = "2011",
doi = "10.1504/IJNT.2011.037173",
language = "English (US)",
volume = "8",
pages = "115--145",
journal = "International Journal of Nanotechnology",
issn = "1475-7435",
publisher = "Inderscience Enterprises Ltd",
number = "1-2",

}

TY - JOUR

T1 - Nanopharmaceuticals II

T2 - Application of nanoparticles and nanocarrier systems in pharmaceutics and nanomedicine

AU - Wu, Xiao

AU - Mansour, Heidi -

PY - 2011

Y1 - 2011

N2 - The principle aim of using nanoparticles in pharmaceutical delivery systems is to enable targeted and efficient delivery of the appropriate levels of therapeutic or diagnostic agents to the target sites with reduced, if any, side effects to the patient. Given the benefits that nanotechnology offers, much effort has focused on producing nanoparticles for the delivery of drugs (particularly anti-tumour drugs), photosensitisers, diagnostic agents and vaccines. These nanosystems can be modified to achieve desirable biological properties (e.g., long circulation in blood, targeting delivery, stimuli sensitivity and intracellular target) and perform various therapeutically or diagnostically important functions simultaneously. This paper reviews the application of nanoparticulate systems in vaccination, chemotherapy, photodynamic therapy, diagnostics, and drug/gene delivery. Multifunctional nanocarriers are also described. Additionally, nanopharmaceutical product development and related issues are briefly presented.

AB - The principle aim of using nanoparticles in pharmaceutical delivery systems is to enable targeted and efficient delivery of the appropriate levels of therapeutic or diagnostic agents to the target sites with reduced, if any, side effects to the patient. Given the benefits that nanotechnology offers, much effort has focused on producing nanoparticles for the delivery of drugs (particularly anti-tumour drugs), photosensitisers, diagnostic agents and vaccines. These nanosystems can be modified to achieve desirable biological properties (e.g., long circulation in blood, targeting delivery, stimuli sensitivity and intracellular target) and perform various therapeutically or diagnostically important functions simultaneously. This paper reviews the application of nanoparticulate systems in vaccination, chemotherapy, photodynamic therapy, diagnostics, and drug/gene delivery. Multifunctional nanocarriers are also described. Additionally, nanopharmaceutical product development and related issues are briefly presented.

KW - Chemotherapy

KW - Diagnostics

KW - Multifunctional

KW - Nanomedicine

KW - Nanoparticles

KW - Photodynamic therapy

KW - Theragnostics

KW - Therapeutics

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=78649711455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649711455&partnerID=8YFLogxK

U2 - 10.1504/IJNT.2011.037173

DO - 10.1504/IJNT.2011.037173

M3 - Article

AN - SCOPUS:78649711455

VL - 8

SP - 115

EP - 145

JO - International Journal of Nanotechnology

JF - International Journal of Nanotechnology

SN - 1475-7435

IS - 1-2

ER -